Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated that study data may help improve the quality of information upon which clinical decisions are based.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Fulfillment of the 1987 American Rheumatism Association criteria for RA
Currently requiring a new DMARD (change or addition)

Exclusion criteria

Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol
Nursing or pregnant women
Patients with active infection

Treatment and study plan

DMARD

Drug

All subjects were required to initiate, add or change DMARD therapy at study entry.

Sponsors and collaborators

Lead sponsor

Amgen

Industry

Collaborators

Immunex Corporation
Wyeth is now a wholly owned subsidiary of Pfizer

Registry information

Official study title

Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 1)

Important dates

Study start: 2001
Primary completion: 2007
Study completion: 2008
First posted: Jul 1, 2005
Registry last updated: May 6, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed